Prestige Consumer Healthcare Inc.PBHReports Thu, Nov 5 · Fiscal 2027 Second Quarter
Health Care · Pharmaceuticals, Biotechnology & Life Sciences · NYSE · United States · prestigebrands.com
Prestige Consumer Healthcare is a consumer healthcare company that markets, sells, manufactures and distributes over-the-counter brands across the U.S., Canada, Australia and select international markets. Its portfolio includes Breathe Right, Monistat, Summer's Eve, BC, Goody's, Dramamine, Fleet, Gaviscon, DenTek, TheraTears, Clear Eyes and Compound W. The company is headquartered in Tarrytown, New York.
Key ratios
Operating cash flow growth
-9.6%TTM
2026
2.4%2025
1.0%2024
8.4%
EPS growth
-16.1%TTM
2026
-8.9%2025
2.9%
FCF / Sales
21.3%TTM
2026
22.6%2025
21.4%2024
21.3%
Net margin
15.6%TTM
2026
17.5%2025
18.9%2024
18.6%
ROA
5.6%2026
2025
6.5%2024
6.4%
ROE
9.1%TTM
2026
10.2%2025
12.3%2024
13.5%
Revenue growth
-1.4%TTM
2026
-4.3%2025
1.1%2024
-0.2%
Recent news
Prestige Consumer Healthcare to Release Fiscal 2027 Second Quarter Earnings Results
Prestige Consumer Healthcare Inc. to Participate in Barclays Global Consumer Conference
Track PBH in your journal
Save it to a watchlist, run a reverse DCF, and keep your notes on the company in one place. Free to start.
Figures are sourced from third parties and shown for research only. They may be delayed or incomplete, and nothing on this page is investment advice or a recommendation to buy or sell. Read the full disclaimer